| 203.31 Delayed Data As of 3:59pm ET |  -0.59 / -0.29%Today’s Change | 108.00 Today|||52-Week Range 208.40 | +44.95% Year-to-Date |
| Why Amgen's Stock Soared in October Nov 11 / MotleyFool.com - Paid Partner Content |
| Previous close | 203.90 |
| Today’s open | 198.32 |
| Day’s range | 198.32 - 208.40 |
| Volume | 377,413 |
| Average volume (3 months) | 344,698 |
| Market cap | $12.0B |
| Earnings growth (last year) | -670.85% |
| Earnings growth (this year) | -1.13% |
| Earnings growth (next 5 years) | +24.00% |
| Revenue growth (last year) | -17.21% |
| P/E ratio | NM |
| Price/Sales | 39.27 |
| Price/Book | 6.81 |
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | +0.13 | +1.26% |
| BBIOBridgeBio Pharma Inc | +3.00 | +9.90% |
| AKRXAkorn Inc | +0.03 | +0.78% |
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$4.97 |
| Annual revenue (last year) | $198.0M |
| Annual profit (last year) | -$673.2M |
| Net profit margin | -339.91% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Beijing, Beijing |
